ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "osteoporosis"

  • Abstract Number: 1206 • ACR Convergence 2020

    Associations of Vascular and Bone Status in Anti-TNF-treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients

    Anita Pusztai1, Attila Hamar2, Monika Czókolyová2, Katalin Gulyás2, Ágnes Horváth2, Edit Végh2, Zsófia Pethő2, Szilvia Szamosi2, Emese Balogh2, Nóra Bodnár2, Ágnes Szentpétery3, Harjit Bhattoa2, György Kerekes2, Balázs Juhász2, Éva Szekanecz2, Katalin Hodosi2, Andrea Domján2, Sándor Szántó2, Hennie Raterman4, Willem Lems5, Zoltán Szekanecz2 and Gabriella Szűcs2, 1University of Debrecen Faculty of Medicine, Department of Rheumatology, Debrecen, Hungary, 2University of Debrecen, Debrecen, Hungary, 3Uppsala University Hospital, Uppsala, Sweden, 4Northwest Clinics, Alkmaar, Netherlands, 5Amsterdam Rheumatology and Immunology Centre, Amsterdam, Netherlands

    Background/Purpose: Cardiovascular (CV) disease and osteoporosis (OP) have become increasing challenges in the ageing population, even more in patients with inflammatory rheumatic diseases, such as…
  • Abstract Number: 0106 • ACR Convergence 2020

    A Machine Learning-derived Radiomics Nomogram for Diagnosis of Osteoporosis and Osteopenia

    Qianrong Xie1, Yue Chen2, Yimei Hu3, Fanwei Zeng4, Pingxi Wang4, Lin Xu5, Jianhong Wu6, Jie Li1, Jing Zhu7, Ming Xiang8 and Fanxin Zeng9, 1Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, China (People's Republic), 2Department of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China (People's Republic), 3Department of Orthopedics, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China (People's Republic), 4Department of bone disease, Dazhou Central Hospital, Dazhou, China (People's Republic), 5Department of medical imaging, Dazhou Central Hospital, Dazhou, China (People's Republic), 6Department of Rheumatology, Dazhou Central Hospital, Dazhou, China (People's Republic), 7Department of Rheumatology and Immunology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, China (People's Republic), 8Department of Orthopedics, Sichuan Provincial Orthopedic Hospital, Chengdu, China (People's Republic), 9Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China (People's Republic)

    Background/Purpose: To discriminate osteoporosis and osteopenia using a quantitative computed tomography (QCT) radiomics signatures and clinical variables.Methods: This retrospective study enrolled 635 patients with QCT images and clinical characteristics from November…
  • Abstract Number: 0124 • ACR Convergence 2020

    Appropriate Timing of Denosumab Dosing and Subsequent Therapy After Discontinuation: An Academic Medical Center Experience

    Hugo Raposo1, Daniel Lindstrom1 and Jonathan Cheah2, 1University of Massachusetts Medical School, Worcester, MA, 2University of Massachusetts Medical School, Shrewsbury, MA

    Background/Purpose: Denosumab, a monoclonal antibody that binds to the receptor activator of nuclear factor kappa-B ligand (RANKL) is a popular choice for osteoporosis therapy. However,…
  • Abstract Number: 1336 • ACR Convergence 2020

    Bone Mineral Density, Trabecular Bone Score and Proximal Femur 3D-DXA Analysis in Psoriatic Diseases

    Eric Toussirot1, Renaud Winzenrieth2, Maxime Desmarets3, Daniel Wendling4, Francois Aubin5 and Gilles Dumoulin6, 1CIC biotherapies, Besançon University Hospital, Besançon, France, 2GALGO medical, Barcelona, Spain, 3INSERM CIC-1431, Besancon, France, 4CHU Besançon, department of rheumatology, Besancon, France, 5Dermatology, Besancon, France, 6Laboratoire de Biochimie Médicale, UF de Biochimie Endocrinienne et Métabolique, Besancon, France

    Background/Purpose: current data regarding areal bone mineral density (aBMD) in patients with psoriasis (PsO) or psoriatic arthritis (PsA) are conflicting. Results on Trabecular Bone Score…
  • Abstract Number: 1971 • 2019 ACR/ARP Annual Meeting

    CD39 Produced from Human Gingiva-Derived Mesenchymal Stem Cells Regulates the Balance of Osteoclasts and Osteoblasts Through Wnt / β-catenin Pathway in Osteoporosis

    Wenbin Wu1, Julie Wang 2, feng huang 1, limin Rong 1 and Song Guo Zheng 3, 1Sun Yat-sen University, Guangzhou, 2Ohio State University, columbus, 3Ohio State College of Medicine, Columbus, OH

    Background/Purpose: Osteoporosis led to severe bone-related diseases and increased mortality and health care costs. Existing treatments failed to reduce the risk of fractures in patients,…
  • Abstract Number: 2222 • 2019 ACR/ARP Annual Meeting

    Bone Health: An Independent Predictor of Coronary Artery Disease

    Lilian Bizzocchi1, Maria Salgado 1, Bhavin Chokshi 1, Navneet Kaur 1, Oscar Mena 1 and Michal Packman 2, 1Jacobi Medical Center, Bronx, NY, 2North Central Bronx Hospital, Bronx, NY

    Background/Purpose: An association between low bone mineral density (BMD) and cardiovascular events has been shown. The calcification process observed in atherosclerosis and bone mineralization have…
  • Abstract Number: 2102 • 2019 ACR/ARP Annual Meeting

    First-line Antiretroviral Therapy with Tenofovir Produces Deleterious Effects on Bone and an Increase in Proinflammatory Cytokines Expression After 12 Months of Treatment in Naïve HIV Patients

    Francisco Conesa-Buendia1, Patricia Atencio 1, Alfonso Cabello 2, Patricia Llamas-Granda 3, Ignacio Mahillo-Fernández 4, Raquel Largo 5, Gabriel Herrero-Beaumont 5, Miguel Gorgolas 1 and Aranzazu Mediero 1, 1IIS-FUNDACION JIMENEZ DIAZ, Madrid, Spain, 2IIS FUNDACION JIMENEZ DIAZ, Madrid, Spain, 3IIS-FUNDACION JIMENEX DIAZ, Madrid, Spain, 4IIS- FUNDACION JIMENEZ DIAZ, Madrid, Spain, 5IIS-Fundación Jiménez Díaz, Madrid, Madrid, Spain

    Background/Purpose: For almost two decades, bone alterations have been observed in the course of HIV infection, characterized by a marked decrease in bone mineral density…
  • Abstract Number: 2224 • 2019 ACR/ARP Annual Meeting

    Parkinson’s Disease and Risk of Fractures : A Meta Analysis of Cohort Studies

    marion louvois1, stéphanie Ferrero 1, Thomas Barnetche 2, christian roux 1 and Véronique Breuil 1, 1university of nice, nice, France, 2university of bordeaux, bordeaux, France

    Background/Purpose: Parkinson's disease is a common neurodegenerative disorder in older adults. Parkinson's patients have an increase risk of falls. More over, previous studies have shown…
  • Abstract Number: 2204 • 2019 ACR/ARP Annual Meeting

    Fragility Fractures in a Community Setting: Clinical Characteristics, Care Gaps, and Outcomes

    Rachel Kneeland1, Keile Wahle 1, Ishwar Gill 1, Yangyang Liu 2 and Monika Starosta 3, 1Department of Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, IL, 2Russell Center for Research & Innovation, Advocate Lutheran General Hospital, Park Ridge, IL, 3Department of Rheumatology, Advocate Lutheran General Hospital, Park Ridge, IL

    Background/Purpose: Osteoporosis-related fragility fractures contribute to significant morbidity and mortality. The risk of subsequent hip fracture is significantly increased after initial fracture, with some reports…
  • Abstract Number: 2225 • 2019 ACR/ARP Annual Meeting

    Systematic Osteoporosis Screening in Chronic Obtructive Pulmonary Disease (Study of Correlation Between Pulmonary Functions Tests and Bone Parameters): Emphysematous Status Is Linked to Low Bone Density and Osteoporosis

    Olivier Malaise1, Cécile André 1, Laurence Seidel 2, Florence Schleich 3, Renaud Louis 3 and Michel Malaise 1, 1Rheumatology department, CHU and University of Liège, Liège, Belgium, 2Biostatistics department, CHU and University of Liège, Liège, Belgium, 3Pneumology department, CHU and University of Liège, Liège, Belgium

    Background/Purpose: Chronic obstructive pulmonary disease (COPD) is usually considered as a risk factor for osteoporosis. However, COPD is an heterogeneous disease with different phenotypes, based…
  • Abstract Number: 151 • 2019 ACR/ARP Annual Meeting

    Implementation of Recommendations for Prevention of Glucocorticosteroid-Induced Osteoporosis in Hospitalized Patients

    Tal Gazitt1, Muna Elias 1, Joy Feld 1, Idit Lavi 1, Amir Haddad 1, Rema Bishara-Garzuzi 1, Muhanad Abu Elhija 1, Adi Kibari 1 and Devy Zisman 2, 1Carmel Hospital, Haifa, Israel, 2Carmel Hospital and Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel, Haifa, Israel

    Background/Purpose: Glucocorticosteroid-induced osteoporosis (GIO) is the most common cause of secondary osteoporosis but is under-diagnosed and under-treated.  Most professional guidelines recommend as a first step…
  • Abstract Number: 2206 • 2019 ACR/ARP Annual Meeting

    MRI-based Textural Analysis of Trabecular Bone: A Novel Method for the Opportunistic Screening of Bone Quality

    Jonathan Cheah1, Matthew Koff 1, Ryan Breighner 1, Bin Lin 1, Conor Jones 2, Janice Havasy 2, Mikas Grewal 1 and Emily Stein 1, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY

    Background/Purpose: A major obstacle to the treatment of osteoporosis and prevention of fractures is that many at-risk patients are never screened. Dual energy x-ray absorptiometry…
  • Abstract Number: 2226 • 2019 ACR/ARP Annual Meeting

    Factors Contributing to Fracture in Pernicious Anemia Patients Presenting with Symptomatic Subacute Vertebral Compression Fractures

    Michael Lovy1, Nir Ben-Shlomo 2 and Jacob Hattenbach 3, 1Desert Oasis Healthcare, Palm Springs, CA, 2Ben-Gurion Medical School, Beer Sheva, Israel, 3College of Osteopathic Medicine of the Pacific, Pomona

    Background/Purpose: Pernicious anemia (PA) has been associated with both low spine BMD and increased fracture risk in retrospective cohort studies.  The cause of these observations…
  • Abstract Number: 270 • 2019 ACR/ARP Annual Meeting

    Outcomes of a Fracture Liaison Service at an Academic Health Center

    Micah Yu1, Donna Jose 2, Parke Hudson 2, Christina Downey, MD 3, Wesley Phipatanakul 2, Silvana Giannelli 2, Kevin Codorniz 4 and Karina Torralba 5, 1Loma Linda University Medical Center, loma linda, 2Loma Linda University, Loma Linda, 3Loma Linda University Medical Center, Loma LInda, CA, 4[email protected], Loma Linda, 5Loma Linda University School of Medicine, Loma Linda, CA

    Background/Purpose: Osteoporosis is associated with increased morbidity and mortality.  There is a 60% risk of a subsequent fracture for patients who have had one fracture,…
  • Abstract Number: 2207 • 2019 ACR/ARP Annual Meeting

    Bone Mineral Density and Microarchitecture Among Chinese Patients with Rheumatoid Arthritis

    Shangyi Jin1, Evelyn Hsieh 2, Weibo Xia 3, Mengtao Li 4, Qian Wang 1 and Xiaofeng Zeng 1, 1Department of Rheumatology, Key Laboratory of Rheumatology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, People’s Republic of China, Beijing, Beijing, China (People's Republic), 2Section of Rheumatology, Yale School of Medicine, NewHaven, CT, 3Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, Beijing, China (People's Republic), 4Dept. of Rheumatology, Peking Union Medical College Hospital (West Campus), Beijing, China, Beijing, China (People's Republic)

    Background/Purpose: To evaluate alterations of bone mineral density and microarchitecture in patients with rheumatoid arthritis (RA). We also aimed to identify potential factors associated with…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology